Campaign will coincide with Esophageal Cancer Awareness Month and will be featured at the upcoming Digestive Disease Week (DDW) Conference NEW YORK, March 27, 2025 /PRNewswire/ -- Lucid...

EarthX and Sustainable Brands® (SB) proudly announce the recognition of 10 Brand Heroes that exemplify commitment to marketplace changes that have the power to advance a more sustainable future....

Advanced patient assessment system enhances monitoring effectiveness and improves patient safety NOBLESVILLE, Ind., March 27, 2025 /PRNewswire-PRWeb/ -- Collette Health, a leader in integrated...

Data highlights preclinical efficacy and safety of GNX1021, a novel glycan-targeting ADC, in gastric cancer models NEW TAIPEI CITY, Taiwan, March 27, 2025 /PRNewswire/ -- GlycoNex, Inc. (4168,...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH) today announced new analyses of the initial Phase 3 program of ampreloxetine (Studies 169 and 170) supporting...